The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
a big part of the manner in which apo e4 transmits its risk to the individual is through an energy crisis much of what you said had to do with substrate it had to do with reducing the utilization of and or access to substrate is that a fair assessment that is one hypothesis it's a prevailing energy hypothesis that links apoe4 with disease and aging
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
you could also have an energy slash inflammation differences that predispose apoe4 to neural inflammation and that by itself could lead to an accelerated disease pathway